Erratum to: " Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis c related cirrhosis or hepatocellular carcinoma" [CLINRE 36 (4) (2012) 345-51] DOI: 10.1016/j.clinre.2012.06.013;Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 4, 2012, Pages 345-351

  Couvert, Philippe ^a,b,c   Carrié, Alain ^a,b,c   Tezenas du Montcel, Sophie ^c   Vaysse, Jenny ^d   Sutton, Angela ^d   Barget, Nathalie ^d,e   Trinchet, Jean Claude ^d,e   Beaugrand, Michel ^d,e   Ganne, Nathalie ^d,e   Giral, Philippe ^a,b,c   Chelly, Jamel ^f,g  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL JEAN VERDIER   (France)

^e UNIVERSITÉ PARIS 13   (France)

^f INSTITUT COCHIN   (France)

^g Paris 13 University ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BISULFITE; CELL DNA; FOLIC ACID; SOMATOMEDIN B;

ADULT; AGE; ALLELE; ARTICLE; BLOOD DONOR; BODY MASS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA ISOLATION; DNA METHYLATION; FEMALE; FLUORESCENCE ANALYSIS; FOLIC ACID BLOOD LEVEL; GENDER; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION;

EID: 84865958584     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.10.001     Document Type: Erratum

References (30)

1. Le Roith D. Insulin-like growth factors. N Engl J Med 1997, 336:633-640.
2. Le Roith D., Roberts C. The insulin-like growth factor system and cancer. Cancer Lett 2003, 195:127-137.
3. Scharf J., Braulke T. The role of IGF axis in hepatocarcinogenis. Horm Metab Res 2003, 35:685-693.
4. Lin S., Hsieh S., Hsu H., Lai M., Kan L., Au L. Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II. J Biochem (Tokyo) 1997, 122:717-722.
5. Rogler C., Yang D., Rossetti L., Donohoe J., Alt E., Chang C., et al. Altered body composition and increased frequency of diverse malignacies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994, 269:13779-13784.
6. Tsai J., Jeng J., Chuang L., You H., Ho M., Lai C., et al. Serum insulin-like growth factor-II and alfa-fetoprotein as tumor markers of hepatocellular carcinoma. Tumor Biol 2003, 24:291-298.
7. Thorgeirsson S., Grisham J. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002, 31:339-346.
8. Falls J., Pulford D., Wylie A., Jirtle R. Genomic imprinting: implications for human disease. Am J Pathol 1999, 154:635-647.
9. Reik W., Walter J. Genomic imprinting: parental influence on the genome. Nat Genet Rev 2001, 2:21-32.
10. Sohda T., Yun K., Iwata K., Soejima H., Okumura M. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab Invest 1996, 75:307-311.
11. Cariani E., Lasserre C., Seurin D., Hamelin B., Kemeny F., Franco D., et al. Differential expression of insulin-like growth factor-II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 1988, 48:6844-6849.
12. Aihara T., Noguchi S., Miyoshi Y., Nakano H., Sasaki Y., Nakamura Y., et al. Allelic imbalance of insulin-like growth factor-II gene expression in cancerous and precancerous lesions of the liver. Hepatology 1998, 28:86-89.
13. Takeda S., Kondo M., Kumada T., Koshikawa T., Ueda R., Nishio M., et al. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 1996, 12:1589-1592.
14. Breuhahn K., Schirmacher P. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol 2008, 14:1690-1698. PMID: 18350600.
15. Uchida K., Kondo M., Takeda S., Osada H., Takahashi T., Nakao A., et al. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 1997, 18:193-198.
16. Li X., Nong Z., Ekstrom C., Larsson E., Nordlinder H., Hofmann W., et al. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 1997, 57:2048-2054.
17. Cui H., Onyango P., Brandenburg S., Yiquian W., Hsieh C., Feinberg A. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002, 62:6442-6446.
18. Feinberg A. Imprinting of domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res 1999, 59:1743-1746.
19. Poirier K., Chalas C., Tissier F., Couvert P., Mallet V., Carrié A., et al. Loss of maternal-specific methylation at the IGF2 locus in human hepatocellular carcinoma. J Pathol 2003, 201:473-479.
20. Couvert P., Carrie A., Paries J., Vaysse J., Miroglio A., Kerjean A., et al. Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma. World J Gastroenterol 2008, 14:5419-5427. PMID: 18803353.
21. Cui H., Cruz-Correa M., Giardiello F., Hutcheon D., Kafonek D., Brandenburg S., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
22. Paz M.F., Avila S., Fraga M.F., Pollan M., Capella G., Peinado M.A., et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002, 62:4519-4524. PMID: 12154064.
23. Castro R., Rivera I., Ravasco P., Camilo M.E., Jakobs C., Blom H.J., et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C-->T and 1298A-->C mutations are associated with DNA hypomethylation. J Med Genet 2004, 41:454-458. PMID: 15173232.
24. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. PMID: 16250051.
25. Boyd V.L., Zon G. Bisulfite conversion of genomic DNA for methylation analysis: protocol simplification with higher recovery applicable to limited samples and increased throughput. Anal Biochem 2004, 326:278-280. PMID: 15003570.
26. Couvert P.K., Poirier A., Carrié C., Chalas P., Jouannet C., Beldjord A., et al. A DHPLC-based method for DNA methylation analysis of differential methylated regions from imprinted genes. Biotechniques 2003, 34:356-362.
27. Dombrowski F., Mathieu C., Evert M. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. Cancer Res 2006, 66:1833-1843. PMID: 16452245.
28. Chao L.T., Wu C.F., Sung F.Y., Lin C.L., Liu C.J., Huang C.J., et al. Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Carcinogenesis 2011, 32:876-881. PMID: 21464041.
29. Nkontchou G., Cosson E., Aout M., Mahmoudi A., Bourcier V., Charif I., et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 2011, 96:2601-2608. PMID: 21752887.
30. Vu T.H., Li T., Nguyen D., Nguyen B.T., Yao X.M., Hu J.F., et al. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics 2000, 64:132-143. PMID: 10729220.